Semaglutide-Glycine-Cyanocobalamin Injectable
Northwest Compounders is recalling Semaglutide-Glycine-Cyanocobalamin Injectable vials due to lack of assurance of sterility.
Do not use this medication. Contact your pharmacy or healthcare provider immediately for a replacement or alternative treatment. Return the product to your pharmacy.
Why it was recalled
Northwest Compounders (Beaverton, OR) is recalling Semaglutide-Glycine-Cyanocobalamin Injectable in 0.5 mL vials (2.5 mg, 5 mg, and 1 mg/mL strengths) due to lack of assurance of sterility. The affected product is a prescription injectable medication distributed by Payless Compounders, LLC.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Beaverton, OR
- Recall #
- D-0471-2026
Where it was sold
Distributed in Oregon.
Official source
Editorial summary by Recall Canary · last updated 2026-04-27 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification